What Is Retatrutide (LY3437943)? Research Overview

Retatrutide, developed under the code LY3437943, is the newest and most-discussed compound in the metabolic peptide cluster. It is the first single-molecule triple receptor agonist to reach broad attention, engaging three distinct incretin and metabolic pathways at once. This overview covers what retatrutide is, the receptors it targets, and what laboratory research examines. For in-vitro laboratory research only.

What is retatrutide?

Retatrutide is a synthetic peptide engineered as a unimolecular triple agonist — a single chain that activates three receptors. It belongs to the incretin-mimetic class, the same broad family as semaglutide and tirzepatide, but extends the design by adding a third receptor target. Researchers study it as the leading example of multi-receptor metabolic pharmacology. The retatrutide research kit is supplied lyophilized in multi-vial research kits.

What receptors does retatrutide target?

Retatrutide is a triple agonist of three receptors that govern overlapping metabolic pathways:

• GLP-1 receptor (glucagon-like peptide-1) — central to appetite-regulation and glucose-dependent insulin-signaling models
• GIP receptor (glucose-dependent insulinotropic polypeptide) — studied for its role in insulin secretion and lipid handling
• Glucagon receptor — the third target, investigated in energy-expenditure and hepatic-metabolism models

Adding glucagon-receptor agonism to the GIP/GLP-1 pair is the defining feature. Whereas tirzepatide engages two receptors, retatrutide engages all three, which is why it sits at the frontier of receptor-pharmacology research. See the side-by-side breakdown in tirzepatide vs retatrutide.

Mechanism class and why the glucagon arm matters

The first two arms — GIP and GLP-1 — are incretin receptors, broadly associated with appetite signaling and glucose-dependent insulin regulation. The glucagon receptor is mechanistically distinct: in research models glucagon-receptor activity is examined in the context of energy expenditure and hepatic (liver) metabolism. Combining all three in one molecule lets researchers study whether simultaneous engagement of these pathways produces different in-vitro outcomes than single- or dual-agonism.

What is retatrutide studied for in research?

In laboratory settings retatrutide is used as a reference standard in receptor-binding and signaling assays — examining potency and selectivity across its three targets — and in metabolic models that look at appetite-regulation, insulin-signaling, and energy-expenditure pathways. It frequently appears as a comparator alongside tirzepatide and semaglutide to map how receptor count relates to measured pathway activity.

How the research kit is supplied

Retatrutide ships lyophilized (freeze-dried) in multi-vial research kits from our US facility within 48 hours with tracking. Before use in research it is reconstituted with bacteriostatic water; the reconstitution calculator computes concentration and aliquot volumes for any vial size. Order the retatrutide reference standard directly.